BGV is focused on early stage European biotech companies. The life science VC firm has a strong track record through investing in healthcare innovations and providing the expertise to build world-class teams. Since its inception BGV raised over €220 million across four funds. BGV is based in Naarden, The Netherlands, and collaborates with Forbion.